FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2906408973> ?p ?o ?g. }

• W2906408973 abstract "Purpose: This study aims to describe a 12-month medication adherence with oral anticancer medications (OAMs) in a routine care medication adherence program, and to better characterize non-persistence. Patients and methods: In this observational, one-centered, longitudinal study, medication adherence was monitored electronically while patients were taking part in a medication adherence program for 12 months or until treatment stop. Patients were >18 years and starting or taking one of the following OAMs: letrozole, exemestane, imatinib, sunitinib, capecitabine or temozolomide. Non-persistence was defined as any premature treatment interruption due to patient’s unilateral decision or to a medical decision because of adverse effects. The Kaplan Meier survival function estimate was used to characterize persistence, and Generalized Estimating Equations (GEE) were adopted to fit adherence, a construct combining persistence and implementation. Statistical analyses were performed using the R software package. Results: Forty-three outpatients with various tumor entities were enrolled. Reasons for quitting the medication adherence program and/or OAM medication were characterized as OAM discontinuation due to adverse effects or toxicity (n=5), planned OAM completion time (n=10), OAM failure (cancer relapse) (n=5) and non-compliance to the adherence program (n=3). In persistent patients, the implementation rates were high (from 98% at baseline to 97% at 12 months). Modelled adherence was 87% at 12 months. Conclusion: A better characterization of both persistence and implementation to OAMs in real life settings is crucial for understanding and optimizing medication adherence to OAMs. The complex identification of non-persistence underlines the need to carefully and prospectively assess OAM interruption or treatment switch reasons. The GEE analysis for describing implementation to OAMs will allow researchers and professionals to take advantage of the richness of longitudinal real-time data, to avoid reducing such data through thresholds and to put them into perspective with OAM blood levels." @default.
• W2906408973 created "2019-01-01" @default.
• W2906408973 creator A5003984008 @default.
• W2906408973 creator A5009226294 @default.
• W2906408973 creator A5012008810 @default.
• W2906408973 creator A5045333594 @default.
• W2906408973 creator A5050549195 @default.
• W2906408973 creator A5053170977 @default.
• W2906408973 creator A5059296575 @default.
• W2906408973 creator A5071076758 @default.
• W2906408973 date "2019-01-29" @default.
• W2906408973 modified "2023-10-17" @default.
• W2906408973 title "A Novel Approach to Better Characterize Medication Adherence in Oral Anticancer Treatments" @default.
• W2906408973 cites W1562209281 @default.
• W2906408973 cites W1703780298 @default.
• W2906408973 cites W1741567663 @default.
• W2906408973 cites W1843179041 @default.
• W2906408973 cites W1986122210 @default.
• W2906408973 cites W1989153061 @default.
• W2906408973 cites W1993894977 @default.
• W2906408973 cites W1995705474 @default.
• W2906408973 cites W1996337195 @default.
• W2906408973 cites W2032277213 @default.
• W2906408973 cites W2038615086 @default.
• W2906408973 cites W2039213719 @default.
• W2906408973 cites W2041321861 @default.
• W2906408973 cites W2055916763 @default.
• W2906408973 cites W2068508150 @default.
• W2906408973 cites W2071003201 @default.
• W2906408973 cites W2071573356 @default.
• W2906408973 cites W2101771403 @default.
• W2906408973 cites W2119562205 @default.
• W2906408973 cites W2119914288 @default.
• W2906408973 cites W2120597421 @default.
• W2906408973 cites W2125516466 @default.
• W2906408973 cites W2132278229 @default.
• W2906408973 cites W2138772369 @default.
• W2906408973 cites W2140737508 @default.
• W2906408973 cites W2168618337 @default.
• W2906408973 cites W2277158667 @default.
• W2906408973 cites W2496550845 @default.
• W2906408973 cites W2654687952 @default.
• W2906408973 cites W2737741478 @default.
• W2906408973 cites W569551381 @default.
• W2906408973 doi "https://doi.org/10.3389/fphar.2018.01567" @default.
• W2906408973 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6361826" @default.
• W2906408973 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30761009" @default.
• W2906408973 hasPublicationYear "2019" @default.
• W2906408973 type Work @default.
• W2906408973 sameAs 2906408973 @default.
• W2906408973 citedByCount "18" @default.
• W2906408973 countsByYear W29064089732019 @default.
• W2906408973 countsByYear W29064089732020 @default.
• W2906408973 countsByYear W29064089732021 @default.
• W2906408973 countsByYear W29064089732022 @default.
• W2906408973 countsByYear W29064089732023 @default.
• W2906408973 crossrefType "journal-article" @default.
• W2906408973 hasAuthorship W2906408973A5003984008 @default.
• W2906408973 hasAuthorship W2906408973A5009226294 @default.
• W2906408973 hasAuthorship W2906408973A5012008810 @default.
• W2906408973 hasAuthorship W2906408973A5045333594 @default.
• W2906408973 hasAuthorship W2906408973A5050549195 @default.
• W2906408973 hasAuthorship W2906408973A5053170977 @default.
• W2906408973 hasAuthorship W2906408973A5059296575 @default.
• W2906408973 hasAuthorship W2906408973A5071076758 @default.
• W2906408973 hasBestOaLocation W29064089731 @default.
• W2906408973 hasConcept C105795698 @default.
• W2906408973 hasConcept C121608353 @default.
• W2906408973 hasConcept C126322002 @default.
• W2906408973 hasConcept C127413603 @default.
• W2906408973 hasConcept C187320778 @default.
• W2906408973 hasConcept C197934379 @default.
• W2906408973 hasConcept C23131810 @default.
• W2906408973 hasConcept C27403532 @default.
• W2906408973 hasConcept C2777909004 @default.
• W2906408973 hasConcept C2778715236 @default.
• W2906408973 hasConcept C2779490328 @default.
• W2906408973 hasConcept C2781009140 @default.
• W2906408973 hasConcept C33923547 @default.
• W2906408973 hasConcept C526805850 @default.
• W2906408973 hasConcept C53084192 @default.
• W2906408973 hasConcept C71924100 @default.
• W2906408973 hasConceptScore W2906408973C105795698 @default.
• W2906408973 hasConceptScore W2906408973C121608353 @default.
• W2906408973 hasConceptScore W2906408973C126322002 @default.
• W2906408973 hasConceptScore W2906408973C127413603 @default.
• W2906408973 hasConceptScore W2906408973C187320778 @default.
• W2906408973 hasConceptScore W2906408973C197934379 @default.
• W2906408973 hasConceptScore W2906408973C23131810 @default.
• W2906408973 hasConceptScore W2906408973C27403532 @default.
• W2906408973 hasConceptScore W2906408973C2777909004 @default.
• W2906408973 hasConceptScore W2906408973C2778715236 @default.
• W2906408973 hasConceptScore W2906408973C2779490328 @default.
• W2906408973 hasConceptScore W2906408973C2781009140 @default.
• W2906408973 hasConceptScore W2906408973C33923547 @default.
• W2906408973 hasConceptScore W2906408973C526805850 @default.
• W2906408973 hasConceptScore W2906408973C53084192 @default.
• W2906408973 hasConceptScore W2906408973C71924100 @default.
• W2906408973 hasLocation W29064089731 @default.
• W2906408973 hasLocation W29064089732 @default.

• next